Document ID: chunk:federal_register_of_legislation:F2024C00897:body:0:p15
Version: federal_register_of_legislation:F2024C00897
Segment Type: other
Provision Reference: 
Character Range: 40698–43622

a special medical purpose product for infants as a result of:
               (a) the addition of *inulin-type fructans to the product in accordance with this Standard; and/or
               (b) the use of a substance as a processing aid in accordance with this Code in the manufacture of the product.

            (5) The fluoride content of a special medical purpose product for infants must not exceed:

               (a) if in a powdered or concentrated form—17 μg/100 kJ; and
               (b) if in a 'ready-to-drink' form—24 μg/100 kJ.
            (6)  The amounts in subsection (5) apply to the special medical purpose product for infants as sold.

           2.9.1—33 Protein requirements

            (1) A special medical purpose product for infants must be only derived from one or more of the following proteins:

                (a) cow milk;
               (b) goat milk;
               (c) sheep milk;
               (d) soy protein isolate;

               (e) a partially hydrolysed protein of one or more of the above.

            (2) A special medical purpose product for infants must have a protein content of:
               (a) for a milk-based product—no less than 0.43 g/100 kJ and no more than
              0.72 g/100 kJ; and
               (b) for a product that is not milk-based product—no less than 0.54 g/100 kJ and no more than 0.72 g/100 kJ.

            (3) For the purposes of subsection (2), milk-based product means a special medical purpose product for infants that is derived only from one or more of the following proteins: cow milk; goat milk; sheep milk; a partially hydrolysed protein of one or more of cow milk, goat milk and sheep milk.

            (4) The L-amino acids listed in the table to section S29—3 must be present in a special medical purpose product for infants at a level not less than the corresponding minimum level specified in the table.

            (5) The minimum levels specified in the table to section S29—3 for cysteine and for methionine do not apply if:

               (a)  the minimum amount of combined cysteine and methionine in the special medical purpose product for infants is not less than 15 mg per 100 kJ; and

               (b) the ratio of methionine to cysteine in the special medical purpose product for infants is less than 2 to 1.

            (6) The minimum levels specified in the table to section S29—3 for phenylalanine and for tyrosine do not apply if:

               (a)  the minimum amount of combined phenylalanine and tyrosine in the special medical purpose product for infants is not less than 37 mg per 100 kJ; and

               (b) the ratio of tyrosine to phenylalanine in the special medical purpose product for infants is less than 2 to 1.

            (7) Despite subsections (4), (5) and (6), L-amino acids listed in the table to section S29—3 must only be added to a special medical purpose product for infants